Banque Cantonale Vaudoise’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Banque Cantonale Vaudoise’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317	Sell	2,001 -1,305	-39%	-$176K	﹤0.01%	582
2026 Q1	$422K	Sell	3,306 -279	-8%	-$34.8K	0.02%	525
2025 Q4	$437K	Buy	+3,585	New	+$411K	0.02%	470
2025 Q3	–	Sell	-827	Closed	-$69K	–	869
2025 Q2	$69K	Hold	827	–	–	﹤0.01%	623
2025 Q1	$67K	Buy	+827	New	+$73.9K	﹤0.01%	662
2024 Q3	$124K	Sell	1,253 -13,446	-91%	-$1.32M	0.01%	531
2024 Q2	$1.36M	Buy	14,699 +500	+4%	+$44.8K	0.05%	298
2024 Q1	$1.35M	Buy	14,199 +3,179	+29%	+$295K	0.05%	315
2023 Q4	$984K	Sell	11,020 -2,617	-19%	-$194K	0.04%	348
2023 Q3	$995K	Buy	13,637 +844	+7%	+$67.4K	0.05%	319
2023 Q2	$1.06M	Buy	12,793 +1,021	+9%	+$85.4K	0.05%	328
2023 Q1	$898K	Buy	11,772 +301	+3%	+$25K	0.04%	329
2022 Q4	$953K	Buy	11,471 +3,526	+44%	+$285K	0.05%	309
2022 Q3	$631K	Buy	7,945 +1,485	+23%	+$125K	0.04%	438
2022 Q2	$480K	Buy	6,460 +31	+0.5%	+$2.33K	0.02%	502
2022 Q1	$578K	Sell	6,429 -679	-10%	-$62.7K	0.02%	519
2021 Q4	$796K	Sell	7,108 -1,427	-17%	-$172K	0.03%	470
2021 Q3	$1.07M	Sell	8,535 -37	-0.4%	-$4.76K	0.05%	401
2021 Q2	$1.16M	Buy	8,572 +225	+3%	+$29.6K	0.05%	395
2021 Q1	$1.13M	Buy	8,347 +2,487	+42%	+$372K	0.06%	341
2020 Q4	$825K	Buy	5,860 +3,397	+138%	+$435K	0.05%	354
2020 Q3	$274K	Buy	+2,463	New	+$276K	0.02%	607
2020 Q2	–	Sell	-1,328	Closed	-$103K	–	961
2020 Q1	$103K	Sell	1,328 -1,040	-44%	-$92.1K	0.01%	766
2019 Q4	$225K	Buy	+2,368	New	+$205K	0.02%	701

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Banque Cantonale Vaudoise's XBI Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, selling an estimated $176K and leaving 2,001 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Banque Cantonale Vaudoise first reported a position in XBI in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.36M in Q2 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Banque Cantonale Vaudoise held 2,001 shares of State Street SPDR S&P Biotech ETF worth $317 as of Q2 2026.
Banque Cantonale Vaudoise sold 1,305 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $176K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #582 holding.
Banque Cantonale Vaudoise first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 24 quarters since.
Banque Cantonale Vaudoise's State Street SPDR S&P Biotech ETF position peaked at $1.36M in Q2 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.